openPR Logo
Press release

Infection Control Market to Surge to USD 486.4 Billion by 2035, Driven by Hygiene Advancements and Global Health Priorities

Infection Control Market

Infection Control Market

The global infection control market is set to experience a major transformation, with its estimated value projected to soar from USD 259.1 billion in 2025 to USD 486.4 billion by 2035, marking a compound annual growth rate (CAGR) of 6.5%. This surge reflects a mounting global commitment to hygiene, safety, and disease control, particularly within healthcare settings where infection control protocols are critical.

As hospitals, clinics, and diagnostic laboratories prioritize sterilization and hygiene, the demand for advanced infection control products is expanding. Emerging markets are also contributing to the growth, particularly in Asia-Pacific, as countries intensify their focus on improving healthcare systems post-pandemic.

Unlock detailed analytics - Request your personalized report now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-391

Key Market Segments and Driving Factors

The infection control market is segmented across several dimensions, including product types, applications, end-users, and regions. Among the leading segments, Non-Woven Disposable Products are expected to capture the largest revenue share, accounting for 39.2% of the market in 2025. These products, which include wipes, gowns, and drapes, are valued for their high hygiene standards, cost efficiency, and single-use design, which reduces the risk of cross-contamination. As healthcare settings move toward disposable solutions for infection control, the non-woven disposable segment is experiencing robust growth.

Another significant segment is Surface Disinfection, projected to represent 58.9% of the market revenue by 2025. Given the vital role surface disinfection plays in preventing hospital-acquired infections (HAIs), there is increasing adoption of cleaning agents, automated systems, and wipes for surface hygiene in healthcare facilities. The rise in regulatory standards and infection control guidelines has further accelerated the use of surface disinfectants, ensuring better outcomes for patients and healthcare staff alike.

Hospital Sector Leading Demand for Infection Control Solutions

Hospitals will remain the largest end-user of infection control solutions, holding 26.9% of the market share in 2025. As high-traffic environments with vulnerable populations, hospitals are under pressure to implement strict infection prevention measures to minimize risks. These measures include sterilization equipment, personal protective equipment (PPE), and surface disinfection protocols. With patient safety and healthcare quality regulations tightening globally, hospitals are expected to drive the bulk of market demand, prompting manufacturers to innovate and deliver scalable, cost-effective solutions.

Regional Insights and Growth Potential

Geographically, the North American market will continue to hold a dominant share, bolstered by rising awareness around disease prevention and the adoption of state-of-the-art sterilization and disinfection equipment. Asia-Pacific, particularly China and India, will see the highest growth, driven by increased healthcare infrastructure investments, a higher prevalence of chronic diseases, and government-led health initiatives. The region is poised for significant growth, with China leading the charge with a forecasted CAGR of 8.8% and India close behind at 8.1%.

While North America remains a stronghold for infection control solutions, Europe and Latin America are expected to show steady growth, driven by the increasing adoption of healthcare hygiene protocols and sterilization technologies. Conversely, Brazil and countries in Eastern Europe may experience slower, yet still positive, growth rates.

Competitive Landscape: Industry Leaders and Market Innovation

Leading players in the infection control market include Nordion Inc., Johnson & Johnson Private Limited, Getinge AB, Kimberly-Clark Corporation, and STERIS, among others. These companies are engaged in continuous innovation, offering a range of infection control solutions including sterilization equipment, PPE, and non-woven disposables. The competitive landscape is marked by strategic collaborations, mergers, and acquisitions, with companies focusing on product scalability, operational efficiency, and cost-effective deployment.

Technological advancements in sterilization and disinfection systems are key growth drivers, as companies look to enhance their product offerings to meet the evolving needs of healthcare institutions. Additionally, strict government regulations and international standards for infection control are pushing manufacturers to develop certified and compliant solutions.

Conclusion: A Strong Growth Trajectory

With a growing emphasis on patient safety, sterilization, and hygiene across healthcare settings, the infection control market is poised for significant growth. As demand surges across North America, Asia-Pacific, and Europe, the market is expected to benefit from product innovations, government policies, and technological advancements. The next decade will witness continued expansion, with hospitals and healthcare providers leading the charge in adopting the latest infection control solutions.

As global healthcare systems strive for higher hygiene standards and reduced infection risks, the infection control market will play a crucial role in shaping the future of patient safety and disease prevention worldwide.

Get Full Access of this Report:
https://www.futuremarketinsights.com/reports/infection-control-market

Explore Related Research Reports on Healthcare Domain

Hospital Surgical Disinfectant Market:
https://www.futuremarketinsights.com/reports/hospital-surgical-disinfectant-market

Stethoscope Hygiene Devices Market:
https://www.futuremarketinsights.com/reports/stethoscope-hygiene-devices-market

Medical Germicidal Lamps Market:
https://www.futuremarketinsights.com/reports/medical-germicidal-lamps-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infection Control Market to Surge to USD 486.4 Billion by 2035, Driven by Hygiene Advancements and Global Health Priorities here

News-ID: 4183811 • Views:

More Releases from Future Market Insights Inc.

Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR from 2025 to 2035, Reaching USD 4.2 Billion by 2035.
Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR …
The global market for Inherited Orphan Blood Disorders Therapeutics is poised for substantial growth over the next decade, with projections estimating the market to expand from USD 1.8 billion in 2025 to USD 4.2 billion by 2035. This represents a compound annual growth rate (CAGR) of 9.0%, reflecting the increasing need for targeted therapeutic solutions for rare genetic blood disorders. Inherited orphan blood disorders, such as sickle cell anemia, thalassemia, and
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation in Cardiac Healthcare
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation …
The cardiovascular surgical devices market is undergoing a dynamic transformation, offering significant opportunities for healthcare providers, medical device manufacturers, and patients alike. With an estimated market value of USD 57.9 billion in 2025, the sector is projected to experience robust growth, reaching USD 122.7 billion by 2035. This impressive expansion, at a compound annual growth rate (CAGR) of 7.8%, is propelled by a convergence of factors including the rising incidence
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach USD 36.6 Billion by 2035
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach …
The surgical heart valves market is entering a new era of expansion, projected to grow from USD 8,897.2 million in 2025 to a staggering USD 36,625.0 million by 2035. With a remarkable compound annual growth rate (CAGR) of 15.2% during the forecast period, the sector is set to be one of the fastest-growing segments within the global cardiovascular medical devices industry. As the world grapples with rising cardiovascular disease rates
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reach USD 6.3 Billion by 2035
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reac …
The global paediatric oncology therapeutics market is poised for significant growth, with a projected compound annual growth rate (CAGR) of 8.0%, reaching a market value of USD 6.3 billion by 2035, up from USD 2.9 billion in 2025. This surge is driven by the increasing prevalence of childhood cancers and the escalating demand for advanced, age-specific treatment options. As the global incidence of paediatric cancers rises, the need for effective, safe,

All 5 Releases


More Releases for Infection

Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Infection Prevention Market? In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market? The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization. The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The yeast infection
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications. The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026. The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,